Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.
Latest SPAC News: DWAC fails to pay proxy solicitors, and Ocean Biomedical discovers new therapy that can potentially kill cancerous cells
Trump SPAC fails to pay proxy firm despite tough hunt for votes, Financial Times reports
Executives behind a SPAC Digital World Acquisition Corp (NASDAQ:DWAC) that plans to take Donald Trump’s media business public have failed to pay their proxy solicitors, The Financial Times reported on Saturday.
Digital World Acquisition Corp, set up by Patrick Orlando, has not paid Saratoga Proxy Consulting for its work helping to rally shareholders, report said, citing people familiar with the matter.
READOcean Biomedical discovers new therapy that can potentially kill cancerous cells
Ocean Biomedical and Aesther Healthcare Acquisition Corp. announced the discovery of a therapy that could potentially kill glioblastoma and melanoma cells – two types of cancerous cells – and block the spread of these cells to the lungs.
The company discovered antibodies that can target both CHI3L1, a regulator of a series of cancer-causing pathways, and ICPI, immune checkpoint inhibitors.
The Providence-based biopharma company recently announced it has entered a merger agreement with special purpose acquisition company Aesther Healthcare Acquisition Corp. (NASDAQ:AEHA), which is expected to be complete by the end of 2022. Ocean Biomedical will then become a subsidiary of Aesther Healthcare Acquisition Corp. and the combined company will be renamed Ocean Biomedical Inc.
READ
McKinley Acquisition Corporation (NASDAQ:MKLYU) has filed for a $150 million SPAC to hunt for an innovative target company with an experienced financial team that has dabbled in SPACs before. The new SPAC is offering investors one right to a 1/10 share in each unit with no overfunding of the trust, but it could provide a...
At the SPAC of Dawn The rain of SPACs has continued with four expected to make their debuts during today’s trading sessions after pricing their IPOs overnight. The largest of these, EQV Ventures II (NASDAQ:EVACU), even managed an upsize, making it the largest SPAC IPO since Ares II (NYSE:AACT) pulled together $450 million in 2023....
EQV Ventures II (NASDAQ:EVACU) announced the pricing of its upsized $420 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “EVACU”, Wednesday, July 2, 2025. The new SPAC plans to merge with an energy target involved in upstream exploration or production. EQV II’s management team is led by...
Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....
Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....